L3Harris Technologies, Inc. · LHX · FY2024 Q3 · Calendar Q4 2024
L3Harris raises outlook as bookings and cost savings strengthen
The supplied analysis supports a constructive near-term operating picture: strong bookings, a record backlog, raised guidance, and faster-than-targeted cost savings point to resilient demand and improving execution. The main test is whether these gains convert into durable margins while budget, supply-chain, and contract-execution risks remain manageable.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about LHX FY2024 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current call added record $34 billion backlog and 1.4 book-to-bill, reported run-rate savings above $600 million, raised full-year guidance, and introduced the Palantir partnership as a data and analytics initiative.
Guidance delta
Management raised full-year revenue and EPS guidance, with the analysis citing a $21.1–$21.3 billion revenue target and $12.95–$13.15 EPS target.
Key takeaways
- Q3 results exceeded expectations, supported by record order volume and strong margins.
- Book-to-bill reached 1.4 and backlog reached a record $34 billion.
- LHX NeXt run-rate savings exceeded $600 million and were described as on track toward the $1 billion goal.
- Management highlighted communications, NATO radio, propulsion, and space-missile opportunities.
- The Palantir partnership is being used for internal data operations and customer-facing capabilities.
Management priorities
- Continue the LHX NeXt digital-engineering and cost-management rollout.
- Scale Aerojet Rocketdyne production and pursue propulsion opportunities.
- Expand NATO and international software-defined-radio contracts.
- Use Palantir for AI and analytics integration.
- Shape the portfolio through divestitures and possible small acquisitions.
Follow LHX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 15, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 12, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 31, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Jul 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 2, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 15, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2025 |
| Baird | Outperform | Outperform | Maintain | Jul 25, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 8, 2025 |
| Jefferies | Buy | Buy | Maintain | Mar 31, 2025 |
| B of A Securities | Buy | Buy | Maintain | Feb 4, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 2, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jan 2, 2025 |
| Argus Research | Buy | Hold | Upgrade | Nov 26, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 10, 2024 |
| Alembic Global | Overweight | Neutral | Upgrade | Apr 22, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 12, 2023 |
| Benchmark | Hold | Buy | Downgrade | Apr 27, 2021 |
| Seaport Global | Buy | Buy | Maintain | May 19, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 16, 2020 |
| CFRA | Buy | Buy | Maintain | Feb 4, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Aug 8, 2019 |
| Vertical Research | Buy | Buy | Maintain | Jul 3, 2019 |
| Argus | Buy | Buy | Maintain | Apr 4, 2018 |
| Sterne Agee | Buy | Neutral | Upgrade | Feb 9, 2015 |
| Stifel Nicolaus | Hold | Hold | Maintain | May 21, 2013 |
| Oppenheimer | Underperform | Perform | Downgrade | Mar 6, 2013 |
| Lazard | Sell | Neutral | Downgrade | Oct 15, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $248.51. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Guggenheim | Analyst unavailable | $365 | $248.93 | +46.9% | Sep 14, 2026 |
| Jefferies | Analyst unavailable | $315 | $262.17 | +26.8% | Aug 26, 2026 |
| UBS | Gavin Parsons | $323 | $343.92 | +30.0% | Jan 14, 2026 |
| Truist Financial | Michael Ciarmoli | $364 | $343.76 | +46.5% | Jan 14, 2026 |
| Vertical Research | Robert Stallard | $355 | $350.48 | +42.9% | Jan 13, 2026 |
| Morgan Stanley | Analyst unavailable | $367 | $288.5 | +47.7% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $350 | $299.99 | +40.8% | Oct 15, 2025 |
| Susquehanna | Charles Minervino | $300 | $260.96 | +20.7% | Jul 14, 2025 |
| Morgan Stanley | Kristine Liwag | $260 | $230.68 | +4.6% | Dec 19, 2024 |
| Jefferies | Sheila Kahyaoglu | $295 | $245.07 | +18.7% | Oct 30, 2024 |
| Citigroup | Jonathan Raviv | $291 | $244.52 | +17.1% | Oct 24, 2024 |
| Bernstein | Douglas Harned | $289 | $242.35 | +16.3% | Oct 11, 2024 |
| Wolfe Research | Myles Walton | $300 | $241.64 | +20.7% | Oct 10, 2024 |
| Deutsche Bank | Scott Deuschle | $250 | $244.66 | +0.6% | Oct 3, 2024 |
| Jefferies | Sheila Kahyaoglu | $275 | $230.09 | +10.7% | Aug 23, 2024 |
| RBC Capital | Sector Perform | $240 | $227.88 | -3.4% | Aug 14, 2024 |
| Morgan Stanley | Kristine Liwag | $257 | $230.62 | +3.4% | Aug 9, 2024 |
| Deutsche Bank | Scott Deuschle | $257 | $243.27 | +3.4% | Jul 26, 2024 |
| Deutsche Bank | Bryan Keane | $295 | $222.45 | +18.7% | Jun 19, 2024 |
| Wells Fargo | Matthew Akers | $245 | $214.75 | -1.4% | May 7, 2024 |
| Barclays | David Strauss | $245 | $217.06 | -1.4% | Apr 30, 2024 |
| RBC Capital | Ken Herbert | $250 | $215.63 | +0.6% | Apr 29, 2024 |
| US Capital Advisors | Peter Skibitski | $238 | $208.14 | -4.2% | Apr 22, 2024 |
| Robert W. Baird | Peter Arment | $219 | $180.12 | -11.9% | Oct 31, 2023 |
| Raymond James | Brian Gesuale | $210 | $174.36 | -15.5% | Oct 30, 2023 |
| Wells Fargo | Jonathan Raviv | $193 | $175.98 | -22.3% | Sep 18, 2023 |
| Wells Fargo | Matthew Akers | $209 | $172.72 | -15.9% | Sep 18, 2023 |
| Robert W. Baird | Peter Arment | $222 | $203.33 | -10.7% | Jul 26, 2023 |
| Credit Suisse | Scott Deuschle | $240 | $194.68 | -3.4% | Mar 27, 2023 |
| Wells Fargo | Analyst unavailable | $230 | $214.77 | -7.4% | Feb 1, 2023 |
| Cowen & Co. | Analyst unavailable | $240 | $199.91 | -3.4% | Jan 12, 2023 |
| Wells Fargo | Analyst unavailable | $219 | $201.95 | -11.9% | Jan 11, 2023 |
| Morgan Stanley | Analyst unavailable | $278 | $218.04 | +11.9% | Dec 15, 2022 |
| J.P. Morgan | Analyst unavailable | $250 | $215.61 | +0.6% | Dec 12, 2022 |
| RBC Capital | Ken Herbert | $285 | $231.97 | +14.7% | Aug 30, 2022 |
| Jefferies | Sheila Kahyaoglu | $300 | $235.21 | +20.7% | May 3, 2022 |
| Susquehanna | Analyst unavailable | $298 | $232.38 | +19.9% | May 2, 2022 |
| Raymond James | Analyst unavailable | $290 | $236.2 | +16.7% | Apr 29, 2022 |
| Jefferies | Sheila Kahyaoglu | $320 | $250.11 | +28.8% | Mar 14, 2022 |
| J.P. Morgan | Seth Seifman | $237 | $209 | -4.6% | Feb 1, 2022 |
| Susquehanna | Charles Minervino | $255 | $209 | +2.6% | Feb 1, 2022 |
| Wolfe Research | Michael Maugeri | $266 | $227.86 | +7.0% | Jan 14, 2022 |
| Goldman Sachs | Noah Poponak | $207 | $219.25 | -16.7% | Sep 23, 2021 |
| Cowen & Co. | Gautam Khanna | $250 | $219.05 | +0.6% | Sep 16, 2021 |
| Credit Suisse | Robert Spingarn | $254 | $226.35 | +2.2% | Aug 4, 2021 |
Track every rating change on LHX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationL3Harris Technologies, Inc. is a prominent technology firm specializing in aerospace and defense, delivering vital, high-stakes solutions to governmental and commercial clients across the globe. Its diverse operations are organized into several key segments: The Integrated Mission Systems division is responsible for providing versatile intelligence, surveillance, and reconnaissance (ISR) platforms, alongside various communication technologies. This unit also offers comprehensive support for fleet management, as well as the development, modification, and routine maintenance of sensors for ISR and airborne operations. Furthermore, it develops and integrates specialized mission systems tailored for naval vessels and maritime operations, including sophisticated signals and multi-intelligence platforms, autonomous surface and undersea vehicles, and advanced power and ship control electronics. Cutting-edge electro-optical and infrared technologies are also part of its offerings.…
Historical context
All LHX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the LHX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-18T19:20:41.496960+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T19:20:41.494035+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.